Programme testing for BRCA mutation to resume next year after successful launch results, Health Secretary tells JC ...

A look at faulty BRCA genes that raise women's risk of breast and ovarian cancer: —BRCA1 and BRCA2 are uncommon. They are thought to account for about 5 percent to 10 percent of all breast cancers, ...

Researchers at the University of Cambridge have created the world's largest catalog of human breast cells, which has revealed early cell changes in healthy carriers of BRCA1 and BRCA2 gene mutations.

Since the NHS Jewish BRCA Testing Programme began in January 2023, around 11,000 saliva tests have been processed, with 235 people (2.1%) testing positive for a BRCA gene mutation, according to new ...

Hundreds of people with Jewish ancestry have been identified as having a gene mutation which puts them at a higher risk of developing cancer. The NHS in England initiated a genetic testing programme ...

Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants are offered surgery to remove the ovaries and fallopian tubes as this dramatically reduces their risk of ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...